Skip to content

Recent Press Releases

Aug 26, 2014

Allergan to Request California Federal Court Block Valeant and Pershing Square from Voting Shares Acquired in Violation of Insider Trading Laws  

Aug 22, 2014

Allergan Receives Written Requests from Pershing Square Regarding Special Meeting of Stockholders  

Aug 20, 2014

Beauty School is In Session--Create a No-Makeup, Makeup Look  

Aug 19, 2014

Nearly Half of Women in New Survey Reveal that Their Current Treatments are Not Adequately Addressing Overactive Bladder (OAB) Symptoms  

Aug 18, 2014

Allergan Names Jim Hindman Chief Financial Officer  

Aug 13, 2014

Allergan Acquires LiRIS® Program from TARIS Biomedical®  

Aug 11, 2014

Allergan Receives Second Request from Federal Trade Commission Regarding Valeant's Unsolicited Acquisition Proposal  

Aug 6, 2014

Allergan Comments on ISS and Glass Lewis Recommendations  

Aug 5, 2014

Allergan Comments on Valeant's Second Quarter 2014 Earnings Results  

Aug 4, 2014

Allergan R&D Innovations Recognized with Three Nominations for the 2014 U.S. Prix Galien Awards  

Aug 1, 2014

Allergan Files Lawsuit in Federal Court against Valeant and Pershing Square for Violations of Federal Securities Laws  

Jul 25, 2014

Allergan Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in applicator) Receives European Positive Opinion for the Treatment of Diabetic Macular Edema  

Jul 21, 2014

Allergan Reports Second Quarter 2014 Operating Results  

Jul 18, 2014

Allergan Announces Quarterly Conference Call  

Jul 14, 2014

Allergan Files Investor Presentation  

Jul 11, 2014

Allergan Comments on Pershing Square's Definitive Proxy Solicitation  

Jun 30, 2014

Allergan Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET  

Jun 23, 2014

Allergan Board of Directors Unanimously Rejects Unsolicited Exchange Offer from Valeant  

Jun 18, 2014

Allergan Board of Directors to Review Unsolicited Exchange Offer from Valeant  

Jun 16, 2014

Allergan Reiterates its Belief that Valeant's Business Model is Unsustainable  

Showing 1-20 of 389
Page: 1 2 3 ... 20
 Next 20